A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

Science PFS Research
#1

FULL TEXT
https://onlinelibrary.wiley.com/doi/full/10.1111/bju.14057

#2

<<In the present study, retrograde ejaculation was reported in 9% of patients in the DUT‐TAM FDC therapy group vs 1% in the placebo group, although this should be more accurately described as anejaculation as described by Wolters and Hellstrom [35]>>

#3

Thanks for sharing but this study only represents a sample group of men over 50. A majority of users in this forum are younger, I would imagine? Doesn’t make it any less credible, but men over 50 are already dealing with erectile issues unrelated to 5ari.

“Patients were sexually active men (i.e. engaged in sexual activity with a partner during the past 4 weeks and plans to be active during the next 4 weeks) aged ≥50 years, with a confirmed clinical diagnosis of BPH”

2 Likes
#4

That’s why there is a control group.